Isordil: Reliable Angina Prevention and Symptom Relief
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.86 | $51.60 (0%) | 🛒 Add to cart |
| 90 | $0.64 | $77.40 $57.62 (26%) | 🛒 Add to cart |
| 120 | $0.52 | $103.20 $61.92 (40%) | 🛒 Add to cart |
| 180 | $0.43 | $154.80 $77.40 (50%) | 🛒 Add to cart |
| 270 | $0.39 | $232.20 $104.06 (55%) | 🛒 Add to cart |
| 360 | $0.36
Best per pill | $309.60 $129.86 (58%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.73 | $43.86 (0%) | 🛒 Add to cart |
| 90 | $0.60 | $65.79 $54.18 (18%) | 🛒 Add to cart |
| 120 | $0.48 | $87.72 $57.62 (34%) | 🛒 Add to cart |
| 180 | $0.36 | $131.58 $64.50 (51%) | 🛒 Add to cart |
| 270 | $0.32 | $197.37 $87.72 (56%) | 🛒 Add to cart |
| 360 | $0.30
Best per pill | $263.16 $108.36 (59%) | 🛒 Add to cart |
Isordil (isosorbide dinitrate) is a long-established nitrate vasodilator prescribed for the prevention and treatment of angina pectoris. It functions by relaxing and widening blood vessels, which reduces cardiac workload and improves oxygen supply to the heart muscle. This medication is a cornerstone in the management of chronic stable angina, offering predictable prophylaxis against exertional chest pain. Proper dosing and adherence to prescribing guidelines are essential to maximize therapeutic efficacy and minimize potential adverse effects.
Features
- Active ingredient: Isosorbide dinitrate
- Available formulations: Sublingual tablets, chewable tablets, oral tablets, and extended-release capsules
- Mechanism of action: Venous and arterial vasodilation via nitric oxide donation
- Onset of action: Sublingual/chewable forms act within 2–5 minutes; oral tablets within 20–60 minutes
- Duration of effect: Varies by formulation, from 2–6 hours for immediate-release to 8–12 hours for sustained-release
- Prescription status: Available by prescription only
Benefits
- Reduces frequency and severity of angina attacks
- Decreases myocardial oxygen demand through preload and afterload reduction
- Provides rapid symptomatic relief when used sublingually for acute episodes
- Supports increased exercise tolerance and functional capacity in patients with chronic angina
- Offers flexible dosing regimens tailored to individual patient needs and angina patterns
- Well-established safety profile with decades of clinical use and evidence
Common use
Isordil is primarily indicated for the prophylactic management of angina pectoris. It is used to prevent expected angina episodes (e.g., prior to physical exertion or stressful events) and to treat acute angina attacks when administered via sublingual or chewable formulations. The medication is typically incorporated into long-term management plans for patients with chronic coronary artery disease, often alongside beta-blockers, calcium channel blockers, and antiplatelet therapy. Healthcare providers may also consider Isordil in certain cases of congestive heart failure for afterload reduction, though this is an off-label application requiring careful clinical judgment.
Dosage and direction
Dosage must be individualized based on patient response, formulation, and clinical context. Sublingual tablets: 2.5–10 mg every 2–3 hours as needed for acute angina or 5–30 minutes before activities known to provoke angina. Chewable tablets: 5 mg as needed, with effect typically beginning within 2–5 minutes. Oral tablets: Initial dose 5–20 mg two or three times daily, with maintenance doses typically ranging from 10–40 mg three times daily. Extended-release capsules: 40 mg once or twice daily. Dosing should be structured to provide a nitrate-free interval of 10–14 hours daily to prevent tolerance development. Tablets should not be crushed or divided; capsules should be swallowed whole. Sublingual administration requires placement under the tongue until fully dissolved without swallowing.
Precautions
Patients should be advised to sit or lie down when taking initial doses due to possible orthostatic hypotension. Alcohol consumption may potentiate hypotensive effects and should be avoided. Abrupt discontinuation may precipitate rebound angina. Tolerance to antianginal effects may develop with continuous dosing, necessitating nitrate-free intervals. Use with caution in patients with hypovolemia, hypotension, or hypertrophic cardiomyopathy. Headaches are common initially but often diminish with continued therapy. Patients should inform all healthcare providers about their nitrate therapy before undergoing surgical or diagnostic procedures. Regular monitoring of blood pressure and heart rate is recommended, especially during dose titration.
Contraindications
Isordil is contraindicated in patients with known hypersensitivity to nitrates or any component of the formulation. Concomitant use with phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil) is absolutely contraindicated due to risk of severe hypotension and cardiovascular collapse. Additional contraindications include severe anemia, increased intracranial pressure, and closed-angle glaucoma. Should not be used in patients with cardiogenic shock or extreme hypotension (systolic BP <90 mmHg). Not recommended in the immediate setting of acute myocardial infarction where vasodilation could compromise coronary perfusion.
Possible side effects
The most common adverse effect is headache (often throbbing and dose-related), occurring in up to 80% of patients, which typically diminishes with continued therapy. Dizziness, lightheadedness, and orthostatic hypotension are frequent, especially during initial treatment. Flushing, reflex tachycardia, and syncope may occur. Gastrointestinal effects include nausea and vomiting. Less commonly reported effects include dermatitis, weakness, and blurred vision. Paradoxical angina and increased myocardial ischemia have been reported rarely. Severe hypotension with nausea, vomiting, weakness, pallor, and perspiration represents a medical emergency requiring immediate attention.
Drug interaction
Concomitant use with phosphodiesterase-5 inhibitors (erectile dysfunction medications) can cause life-threatening hypotension. Additive hypotensive effects occur with other vasodilators, antihypertensives, calcium channel blockers, beta-blockers, tricyclic antidepressants, phenothiazines, and alcohol. Aspirin may increase nitrate serum concentrations. Heparin effectiveness may be reduced. Sympathomimetics may counteract the antianginal effects. Diuretics may potentiate orthostatic hypotension. Concomitant use with riociguat is contraindicated due to hypotensive risk. Always review full medication profile including over-the-counter products before initiation.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. For scheduled prophylactic dosing, maintain the regular dosing schedule. For as-needed sublingual or chewable tablets, take when angina symptoms occur according to prescribed instructions. Patients should not take extra doses beyond the prescribed frequency due to risk of tolerance development and hypotension.
Overdose
Nitrate overdose manifests primarily as vasodilation with severe hypotension, throbbing headache, dizziness, palpitations, visual disturbances, nausea, vomiting, diaphoresis, syncope, and methemoglobinemia (evidenced by cyanosis, hypoxia, fatigue). In severe cases, cardiovascular collapse, coma, or death may occur. Treatment involves immediate discontinuation, elevation of legs, administration of intravenous fluids, and supportive care. Methylene blue may be indicated for methemoglobinemia. Vasopressors may be required for refractory hypotension. Hemodialysis is not effective due to extensive tissue distribution. Seek immediate medical attention for suspected overdose.
Storage
Store at controlled room temperature (20–25°C or 68–77°F) in the original container with lid tightly closed. Protect from light, moisture, and heat. Do not store in bathroom or kitchen where humidity and temperature fluctuations occur. Keep sublingual tablets in their original glass container and avoid transferring to other containers. Do not use if tablets change color or appearance. Keep all medications out of reach of children and pets. Properly discard expired or unused medication through take-back programs or following FDA guidelines.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Isordil is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual response to therapy may vary. Always follow the specific instructions provided by your prescribing physician and pharmacist. Do not adjust dosage or discontinue medication without consulting your healthcare provider. Report any adverse effects or concerns promptly to your medical team.
Reviews
Clinical experience with Isordil spans decades, with extensive evidence supporting its efficacy in angina prophylaxis. Numerous studies demonstrate significant reduction in angina frequency and nitroglycerin consumption. The 2012 American College of Cardiology Foundation/American Heart Association guideline for stable ischemic heart disease continues to recommend nitrates as first-line antianginal therapy. Patient satisfaction surveys indicate improved quality of life and functional capacity when used appropriately. Some reviews note the challenge of dose timing to balance efficacy with tolerance prevention. Overall, Isordil remains a valuable therapeutic option in comprehensive angina management strategies.